UPLOAD Filing
Aptevo Therapeutics Inc.
Date: May 20, 2025 · CIK: 0001671584 · Accession: 0000000000-25-005388
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287244
Letter
Re: Aptevo Therapeutics Inc. Registration Statement on Form S-1 Filed May 13, 2025 File No. 333-287244 Dear Marvin L. White:
May 20, 2025
Marvin L. White President and Chief Executive Officer Aptevo Therapeutics Inc. 2401 4th Avenue, Suite 1050 Seattle, WA 98121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Sean M. Donahue
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 20, 2025 Marvin L. White President and Chief Executive Officer Aptevo Therapeutics Inc. 2401 4th Avenue, Suite 1050 Seattle, WA 98121 Re: Aptevo Therapeutics Inc. Registration Statement on Form S-1 Filed May 13, 2025 File No. 333-287244 Dear Marvin L. White: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Sean M. Donahue </TEXT> </DOCUMENT>